Theratechnologies Inc T.TH

Should NASH be revived

[Joemare]

Through a partnerhsip or go at-it alone strategy, the valuation of THERF would exceed 1B$ market cap in no time.

Cantor -I thought I read here that Cantor had info to write a piece for quite some time. Was her info updated recently?  Was she sitting on old dicussion notes?  And then, why would you say 'partnership' is the road to 300M$.....a little uneasy with this info. Not sure uneasy for a huge postive run for THERF or uneasy that she sat on old info and it's wishful thinking on her end.

[palinc2000]

Duh!!

[qwerty22]

We are back to reading tea leaves again here. All she's really done is state the reality "NASH is on pause" and then repeat the line the company is promoting "they need a partner with the cash and resourses". She's going further than others in assigning future revenue but I'm sure there are plenty of caveats to that in the 54page report. It does look like she's

[canadapiet]

I hope i am wrong but i smell another .......$$$$$!!!  qwerty22 - (11/18/2022 12:05:44 PM) RE:Should NASH be revived  We are back to reading tea leaves again here. All she's really done is state the reality "NASH is on pause" and then repeat the line the company is promoting "they need a partner with the cash and resourses". She's

[ANALIAS00]

At 2.60 can ?

[Biobob]

Maybe Nash ain't dead after all... all kind of Nash companies with less good results than Th getting noticed in the past... Greenspoon and Lomba aren't exactly amateurs... they all said Egrifta works.. then this Covid Flu panic and everything went to sh..t.  

[Joemare]

Although not permitted to support off-label use, curious to know if they know of off-label use and what type of medical activities are done regarding Egrifta in NAFLD/NASH.  

[Joemare]

FYI --- Just out.  November 2022 publication:   Causes and outcomes of hepatic fibrosis in persons living with HIV Abstract Purpose of review: The epidemiology of liver disease in people living with HIV has evolved since the arrival of effective hepatitis C virus (HCV) treatment. Nonalcoholic fatty liver disease (NAFLD) in HIV patients is highly prevalent while

[stephanedodier]

https://www.natap.org/2022/HIV/100322_01.htm Tesamorelin, a growth hormone releasing analog administered subcutaneously once daily and approved by the United States Food and Drug Administration (FDA) for HIV lipodystrophy, is an emerging therapy for HIV-associated NAFLD.

[qwerty22]

I'm pretty sure one of the authors, Kenneth Sherman is a name that's popped up with respect to Tesa/Theratech before.  

[palinc2000]

Recall my post about the rabbit out of the hat could be Nash!!! Not there yet but I see the rabbit s ears and they have a Nash look !!!!

[Lee430]

I believe in magic.

[Biobob]

Maybe they can make my money re-appear....lol

[scarlet1967]

It was posted before! NASH isn't dead but a a deadly disease if not addressed with growing prevalence which is higher in obese individuals including PLWH AND general population. VAT, GH deficiency , insulin resistance etc. have been mentioned numerous times as cusses for and progression of the condition.... the issue with THTX's NASH protocol isn't the potentials of its science but the

[scarlet1967]

TSX:TH Forum Post | scarlet1967-35005612 | THTX's NASH protocol's advantages | Theratechnologies Inc. TSX:TH Forum Post | scarlet1967-35005612 | THTX's NASH protocol's advantages | Theratechnologies Inc. Causes_and_outcomes_of_hepatic_fibrosis_in_persons.6.pdf   https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00317-X/fulltext#%20

[Biobob]

One thing that struck me on the last Q3 call was the subcontracting of their own bacteriologic water supply for F8.... you don't go trough this kind of trouble for Lipo indication, it's already patentless and nobody's rushing to copycat the thing.  So that leaves Nash.

[qwerty22]

NASH is definitely a mixed bag to put it mildly. There's a lot of guessing floating about on combos and fast acting drug followed by maintenance drugs and whether downstream drugs are the thing or precision upstream. The science has moved on somewhat but the regulators haven't much. A lot of bad drugs have fallen, maybe some good ones too. Maybe in all that mess THTX has as good a